Loading clinical trials...
Loading clinical trials...
A Randomized, Double-Blind, Controlled, Parallel Group Study to Evaluate the Efficacy and Safety of FLX-787-ODT for Treatment of Muscle Cramps in Adult Subjects With Charcot-Marie-Tooth Disease
Conditions
Interventions
FLX-787-ODT (orally disintegrating tablet)
Placebo ODT
Locations
20
United States
Mayo Clinic
Scottsdale, Arizona, United States
University of Colorado
Aurora, Colorado, United States
Hospital for Special Care
New Britain, Connecticut, United States
University of Florida
Gainesville, Florida, United States
Mayo Clinic
Jacksonville, Florida, United States
University of South Florida
Tampa, Florida, United States
Start Date
October 16, 2017
Primary Completion Date
July 27, 2018
Completion Date
July 27, 2018
Last Updated
August 29, 2018
NCT06794489
NCT07049588
NCT06881979
NCT06203093
NCT04010188
NCT06218134
Lead Sponsor
Flex Pharma, Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions